Related references
Note: Only part of the references are listed.2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
Maurice B. Bizino et al.
CARDIOVASCULAR DIABETOLOGY (2019)
Sitagliptin improves diastolic cardiac function but not cardiorespiratory fitness in adults with type 2 diabetes
Rebecca L. Scalzo et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2019)
GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials
Dario Giugliano et al.
DIABETES OBESITY & METABOLISM (2019)
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Soren L. Kristensen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Effect of canagliflozin on left ventricular diastolic function in patients with type 2 diabetes
Daisuke Matsutani et al.
CARDIOVASCULAR DIABETOLOGY (2018)
Diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review
Eylem Levelt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: A systematic review and meta-analysis
Selma Bouthoorn et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Liraglutide relieves cardiac dilated function than DPP-4 inhibitors
Takeyuki Hiramatsu et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2018)
Impact of dapagliflozin on left ventricular diastolic function of patients with type 2 diabetic mellitus with chronic heart failure
Fumitaka Soga et al.
CARDIOVASCULAR DIABETOLOGY (2018)
The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways
Gunaj Rakipovski et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2018)
Exenatide improves diastolic function and attenuates arterial stiffness but does not alter exercise capacity in individuals with type 2 diabetes
Rebecca L. Scalzo et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2017)
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R. Holman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Diabetes Mellitus and Heart Failure
Michael Lehrke et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study
Hirotsugu Yamada et al.
CARDIOVASCULAR DIABETOLOGY (2017)
The design-by-treatment interaction model: a unifying framework for modelling loop inconsistency in network meta-analysis
Dan Jackson et al.
RESEARCH SYNTHESIS METHODS (2016)
Effect of Empagliflozin on Left Ventricular Mass and Diastolic Function in Individuals With Diabetes: An Important Clue to the EMPA-REG OUTCOME Trial?
Subodh Verma et al.
DIABETES CARE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Comparison of effects of sitagliptin and voglibose on left ventricular diastolic dysfunction in patients with type 2 diabetes: results of the 3D trial
Hiroki Oe et al.
CARDIOVASCULAR DIABETOLOGY (2015)
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Petar M. Seferovic et al.
EUROPEAN HEART JOURNAL (2015)
Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy
Richard E. Gilbert et al.
LANCET (2015)
Molecular mechanisms of diabetic cardiomyopathy
Heiko Bugger et al.
DIABETOLOGIA (2014)
The microvascular effects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study
Abdulghani M. Larghat et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2014)
A matrix-based method of moments for fitting the multivariate random effects model for meta-analysis and meta-regression
Dan Jackson et al.
BIOMETRICAL JOURNAL (2013)
Graphical Tools for Network Meta-Analysis in STATA
Anna Chaimani et al.
PLOS ONE (2013)
A practical introduction to multivariate meta-analysis
Dimitris Mavridis et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Lack of effects of pioglitazone on cardiac function in patients with type 2 diabetes and evidence of left ventricular diastolic dysfunction: a tissue doppler imaging study
Katerina K. Naka et al.
CARDIOVASCULAR DIABETOLOGY (2010)
Rosiglitazone, but Not Pioglitazone, Improves Myocardial Systolic Function in Type 2 Diabetic Patients: A Tissue Doppler Study
Selcuk Pala et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES (2010)
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
David Moher et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure
Michael R. MacDonald et al.
EUROPEAN HEART JOURNAL (2008)
The risk of heart failure in patients with type 2 diabetes treated with oral agent monotherapy
Finlay A. McAlister et al.
EUROPEAN JOURNAL OF HEART FAILURE (2008)
The potential beneficial role of glucagon-like peptide-1 in endothelial dysfunction and heart failure associated with insulin resistance
T. Nystroem
HORMONE AND METABOLIC RESEARCH (2008)
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies
R Huxley et al.
BMJ-BRITISH MEDICAL JOURNAL (2006)
Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption
YF Guan et al.
NATURE MEDICINE (2005)
Share Paper
